{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:27:31Z","timestamp":1771946851162,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.schres.2007.11.034","type":"journal-article","created":{"date-parts":[[2008,1,14]],"date-time":"2008-01-14T12:44:37Z","timestamp":1200314677000},"page":"39-52","source":"Crossref","is-referenced-by-count":51,"title":["The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: Results from the CATIE study"],"prefix":"10.1016","volume":"100","author":[{"given":"Marvin S.","family":"Swartz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Ryan","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey W.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Scott","family":"Stroup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph P.","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Reimherr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Del D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"McGee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Canive","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John K.","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2007.11.034_bib1","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1037\/0003-066X.46.10.1036","article-title":"Co-occurring disorders among mentally ill jail detainees: implications for public policy","volume":"46","author":"Abram","year":"1991","journal-title":"Am. Psychol."},{"key":"10.1016\/j.schres.2007.11.034_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0920-9964(92)90003-N","article-title":"Reliability and validity of a depression rating scale for schizophrenics","volume":"6","author":"Addington","year":"1992","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2007.11.034_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0272-7358(99)00033-1","article-title":"Substance use disorders in schizophrenia: review, integration, and a proposed model","volume":"20","author":"Blanchard","year":"2000","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.schres.2007.11.034_bib4","first-page":"12","article-title":"New antipsychotic agents: emerging clinical profiles","volume":"60","author":"Buckley","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.034_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0920-9964(00)00114-6","article-title":"Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden","volume":"48","author":"Cantor-Graae","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2007.11.034_bib6","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1176\/ajp.148.9.1225","article-title":"HIV prevalence among patients admitted to two psychiatric hospitals","volume":"148","author":"Cournos","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.034_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/oxfordjournals.schbul.a006993","article-title":"Statistical approaches to effectiveness measurement and outcome-driven re-randomizations in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) studies","volume":"29","author":"Davis","year":"2003","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2007.11.034_bib8","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0920-9964(98)00161-3","article-title":"Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes","volume":"35","author":"Dixon","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2007.11.034_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/schbul\/16.1.57","article-title":"Diagnosis of alcohol use disorders in schizophrenia","volume":"16","author":"Drake","year":"1990","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2007.11.034_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/oxfordjournals.schbul.a033464","article-title":"The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia","volume":"26","author":"Drake","year":"2000","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2007.11.034_bib11","series-title":"Structured Clinical Interview for Axes I and II DSM-IV Disorders-Patient Edition (SCID-I\/P)","author":"First","year":"1996"},{"key":"10.1016\/j.schres.2007.11.034_bib12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1023\/A:1013026318450","article-title":"Recent victimization in women and men with severe mental illness: prevalence and correlates","volume":"14","author":"Goodman","year":"2001","journal-title":"J. Trauma. Stress"},{"key":"10.1016\/j.schres.2007.11.034_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10550490490435795","article-title":"Substance-abusing schizophrenics: do they self-medicate?","volume":"13","author":"Goswami","year":"2004","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.schres.2007.11.034_bib14","first-page":"21","article-title":"Schizophrenia and comorbid substance use disorder: effects of antipsychotics","volume":"66","author":"Green","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.034_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/10673229909017206","article-title":"Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?","volume":"6","author":"Green","year":"1999","journal-title":"Harv. Rev. Psychiatr."},{"key":"10.1016\/j.schres.2007.11.034_bib16","unstructured":"Guy, W., 1976. ECDEU Assessment Manual for Psychopharmacology\u2014Revised (DHEW Publ No. ADM 76-338). U.S. Department of Health, Education, and Welfare. Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, Rockville, MD, pp. 218\u2013222."},{"key":"10.1016\/j.schres.2007.11.034_bib17","first-page":"856","article-title":"Predicting the \u2018revolving door\u2019 phenomenon among patient with schizophrenic, schizoaffective, and affective disorders","volume":"151","author":"Haywood","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.034_bib18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","article-title":"A sharper Bonferroni procedure for multiple tests of significance","volume":"75","author":"Hochberg","year":"1988","journal-title":"Biometrika"},{"key":"10.1016\/j.schres.2007.11.034_bib19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2165\/00003495-200262050-00003","article-title":"Substance misuse in patients with schizophrenia: epidemiology and management","volume":"62","author":"Kavanagh","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.schres.2007.11.034_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2007.11.034_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.schbul.a006990","article-title":"Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale","volume":"29","author":"Keefe","year":"2003","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2007.11.034_bib22","first-page":"1","article-title":"Baseline neurocognitive deficits in the CATIE Schizophrenia Trial","volume":"4","author":"Keefe","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2007.11.034_bib23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia","volume":"64","author":"Keefe","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.034_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/archpsyc.1997.01830160031005","article-title":"Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey","volume":"54","author":"Kessler","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.034_bib25","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.schres.2007.11.034_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0740-5472(01)00205-7","article-title":"Olanzapine treatment for patients with schizophrenia and substance abuse","volume":"21","author":"Littrell","year":"2001","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.schres.2007.11.034_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1192\/bjp.181.4.321","article-title":"Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study","volume":"181","author":"McCreadie","year":"2002","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.034_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00005053-198901000-00007","article-title":"Insight in schizophrenia: its relationship to acute psychopathology","volume":"177","author":"McEvoy","year":"1989","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.schres.2007.11.034_bib29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine, quetiapine and risperidone in patients with chronic schizophrenia who failed prior atypical antipsychotic treatment","volume":"153","author":"McEvoy","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.034_bib30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0306-4603(98)00073-2","article-title":"Dual diagnosis: a review of etiological theories","volume":"23","author":"Mueser","year":"1998","journal-title":"Addict. Behav."},{"key":"10.1016\/j.schres.2007.11.034_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/10550490500419052","article-title":"Atypical antipsychotic medication and substance use-related outcomes in the treatment of schizophrenia","volume":"15","author":"Petrakis","year":"2006","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.schres.2007.11.034_bib32","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study","volume":"264","author":"Regier","year":"1990","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.schres.2007.11.034_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2105\/AJPH.91.1.31","article-title":"Prevalence of HIV, Hepatitis B and Hepatitis C in people with severe mental illness","volume":"91","author":"Rosenberg","year":"2001","journal-title":"Am. J. Public Health"},{"issue":"12","key":"10.1016\/j.schres.2007.11.034_bib34","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1176\/ajp.2006.163.12.2080","article-title":"Cost-effectiveness of first and second generation antipsychotics in the treatment of chronic schizophrenia","volume":"163","author":"Rosenheck","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.034_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0920-9964(00)00063-3","article-title":"Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia","volume":"48","author":"Salyers","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2007.11.034_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/070674370204700710","article-title":"Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence","volume":"47","author":"Smelson","year":"2002","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.034_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.schbul.a006986","article-title":"The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development","volume":"29","author":"Stroup","year":"2003","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2007.11.034_bib38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1176\/ajp.2006.163.4.611","article-title":"Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia after discontinuation of a previous atypical antipsychotic","volume":"163","author":"Stroup","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.034_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00332747.1997.11024781","article-title":"Violence and severe mental disorder in clinical and community populations: the effects of psychotic symptoms, comorbidity, and lack of treatment","volume":"60","author":"Swanson","year":"1997","journal-title":"Psychiatry"},{"key":"10.1016\/j.schres.2007.11.034_bib40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1176\/ajp.155.2.226","article-title":"Violence and severe mental illness: the effects of substance abuse and nonadherence to medication","volume":"155","author":"Swartz","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.034_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.schbul.a006989","article-title":"Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial","volume":"29","author":"Swartz","year":"2003","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2007.11.034_bib42","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.nmd.0000202575.79453.6e","article-title":"Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study","volume":"194","author":"Swartz","year":"2006","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.schres.2007.11.034_bib43","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1176\/ps.2006.57.8.1110","article-title":"Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE Study","volume":"57","author":"Swartz","year":"2006","journal-title":"Psychiatr. Serv."},{"issue":"3","key":"10.1016\/j.schres.2007.11.034_bib44","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/ajp.2007.164.3.428","article-title":"Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE Study","volume":"164","author":"Swartz","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2007.11.034_bib45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-9964(95)00068-2","article-title":"Substance use: a powerful predictor of relapse in schizophrenia","volume":"20","author":"Swofford","year":"1996","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2007.11.034_bib46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00004714-200212000-00017","article-title":"Can risperidone reduce cocaine use in substance abusing schizophrenic patients?","volume":"22","author":"Tsuang","year":"2002","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996407005427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996407005427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T20:30:50Z","timestamp":1684182650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996407005427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":46,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0920996407005427"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2007.11.034","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}